University of Saskatchewan (USask) PhD candidate Josh Neudorf and his research team is using innovative computer technology to map brain function. The research team hopes the computer model of brain connectivity may be able to save the health care system and research centres time and money by decreasing the number of necessary patient brain scans. “The brain...
Month: <span>February 2022</span>
Post
What your sweat says about your health?
Sweating it out through exercise may be a New Year’s resolution but it could also help to provide new insights into the state of your health, according to new sensing technology being developed at Simon Fraser University. SFU researcher Woo Soo Kim is part of an international research team that is developing a low-cost, 3D-printed wearable...
Post
The Slimmest ECG Ever Created: A Review
FEBRUARY 14TH, 2022 ALICE FERNG CARDIOLOGY, EXCLUSIVE, OTC A couple of weeks ago, AliveCor, a leading innovator in the FDA-cleared personal electrocardiogram (ECG) technology space, announced the launch of the KardiaMobile Card. The KardiaMobile Card is the slimmest and smallest self-contained, commercially available ECG that has been created to date. It is the size of a standard credit...
Post
20 mins of daily exercise at 70 may best stave off major heart disease in late old age
BMJ Twenty minutes of daily moderate to vigorous exercise in early old age (70-75) may best stave off major heart disease, including heart failure, in late old age (80+), suggests research published online in the journal Heart. The findings reinforce the maxim of ‘better late than never,’ when it comes to exercise, but earlier on in...
Post
Website for gait strategies Parkinson patients now available
RADBOUD UNIVERSITY MEDICAL CENTER Radboud university medical center launched a platform for people with Parkinson’s Disease. It contains seven gait strategies, which can help the patients with walking. The website will be launched on February 2022, 15. This website about walking difficulties in Parkinson’s disease have been developed for people with Parkinson’s, their loved ones, and...
Post
Monell Center researchers estimate the true prevalence of COVID-19 taste loss
MONELL CHEMICAL SENSES CENTER IMAGE: THE MONELL META-ANALYSIS TASTE TEAM CREDIT: MONELL CHEMICAL SENSES CENTER Reports of taste loss, a symptom of COVID-19, have been on the rise over the last two years. The taste dysfunction comes in different forms, including ageusia (total taste loss), hypogeusia (partial taste loss), and dysgeusia (taste distortion). While taste...
Post
Biomarker Shows Promise for Potential Treatment of Facioscapulohumeral Muscular Dystrophy
IOS PRESS Amsterdam, February 15, 2022 – There is currently no effective treatment for facioscapulohumeral muscular dystrophy (FSHD), one of the most common neuromuscular diseases, which is caused by an abnormal expression of the transcription factor DUX4. Investigators have now identified a novel promising biomarker, interleukin-6 (IL-6), that correlates with the severity of FSHD. This has the...
Post
Psilocybin treatment for major depression effective for up to a year for most patients, study shows
JOHNS HOPKINS MEDICINE IMAGE: CREDIT: GETTY IMAGES CREDIT: GETTY IMAGES Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive...
Post
NOACs associated with lower risk for diabetic complications and mortality compared with warfarin
by American College of Physicians Credit: Unsplash/CC0 Public Domain A retrospective cohort study of patients with atrial fibrillation and diabetes found that the use of non–vitamin K antagonist oral anticoagulants (NOAC) was associated with a lower risk of diabetes complications and mortality than warfarin. These findings suggest that NOAC may be a better therapeutic choice...
Post
Illicit amphetamine (‘speed’) use linked to 5-fold heightened risk of psychosis
by British Medical Journal Credit: CC0 Public Domain The illicit use of amphetamines, the stimulants commonly known as ‘speed’, is linked to a 5-fold heightened risk of psychosis, finds a 10 year study published online in the journal Evidence-Based Mental Health. This increased risk was seen across all age groups, but was especially noticeable among women and...